Musculoskeletal Disorder

Promising avenues in extracellular vesicle-based therapeutics 5:05
Promising avenues in extracellular vesicle-based therapeutics
Eva Rohde • 10 Jun 2021
Tackling unproven cell-based therapies and the impact of COVID-19 7:28
Tackling unproven cell-based therapies and the impact of COVID-19
Aaron Levine • 28 May 2021
Cardiosphere-derived cells in myocardial regeneration 2:01
Cardiosphere-derived cells in myocardial regeneration
Linda Marban • 19 May 2021
Chemically modified mRNA encoding BMP-2 for bone healing 4:10
Chemically modified mRNA encoding BMP-2 for bone healing
Christopher Evans • 19 May 2021
The gene therapy landscape for osteoarthritis 3:36
The gene therapy landscape for osteoarthritis
Christopher Evans • 19 May 2021
The importance of clinical registries & biospecimen analysis in orthobiologics 4:49
The importance of clinical registries & biospecimen analysis in orthobiologics
Nicolas Piuzzi • 7 Jun 2021
Direct-to-consumer marketing of unproven orthopedic therapies 3:29
Direct-to-consumer marketing of unproven orthopedic therapies
Nicolas Piuzzi • 7 Jun 2021
Off-the-shelf cell therapy for bone indications: ALLOB & JTA-004 4:54
Off-the-shelf cell therapy for bone indications: ALLOB & JTA-004
Miguel Forte • 26 May 2021
IL-1Ra gene therapy for knee OA: interim Phase I results 3:02
IL-1Ra gene therapy for knee OA: interim Phase I results
Christopher Evans • 19 May 2021
NextGen & GenX AAV vectors for DMD gene therapy 3:49
NextGen & GenX AAV vectors for DMD gene therapy
Arun Srivastava • 18 May 2021
The content of VJRegenMed is intended for healthcare professionals